$LITS·4

MEI Pharma, Inc. · Aug 1, 5:18 PM ET

MEI Pharma, Inc. 4

4 · MEI Pharma, Inc. · Filed Aug 1, 2016

Insider Transaction Report

Form 4
Period: 2016-07-29
Zech Thomas M.
Chief Financial Officer
Transactions
  • Award

    Option to purchase shares of common stock

    2016-07-29+110,000338,757 total
    Exercise: $1.36Exp: 2026-07-29Common Stock par value $0.00000002 (110,000 underlying)
Footnotes (2)
  • [F1]One-quarter of the options will vest on July 29, 2017; the remaining three-quarters of the options will vest in equal monthly installments over the following thirty-six months.
  • [F2]The total number of derivative securities reported in Column 9 includes previously awarded options, which were subject to the effect of a 1 for 6 reverse stock split, which was effective on December 18, 2012.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION